Docket Management
Docket: 00N-1256 - Over-the-Counter Products
Comment Number: EC -10

Accepted - Volume 6

Comment Record
Commentor Mrs. Felicia Miedema Date/Time 2000-06-27 03:13:14
Organization Mrs. Felicia Miedema
Category Health Professional

Comments for FDA General
Questions
1. General Comments I am in support of the approval of Mevacor and Prevachol as well as Claritin, and ultimately Allegra and Zyrtec for OTC sale. I appreciate the importance of the FDA's role in assuring, first and foremost, the safety of OTC drugs for use by a diverse public with many different medical needs and conditions. However, when drugs are so safe for the vast majority of the public, it is in the public interest to make them available without a prescription. No drug is completely risk free. However, the decision to designate a drug OTC should be made based on its relative safety for the majority of people, NOT on the pharmaceutical companies' profit margin and/or patent issues. This also reduces the cost to insurers, and ultimately insured individuals, who now provide coverage for these drugs.




EC -10